Drug Shortage Report for APO-PREGABALIN

Last updated on 2019-06-17 History
Report ID 83527
Drug Identification Number 02394278
Brand name APO-PREGABALIN
Common or Proper name PREGABALIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-06
Estimated end date 2019-07-01
Actual end date 2019-06-14
Shortage status Resolved
Updated date 2019-06-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-06-17 French Compare
v4 2019-06-17 English Compare
v3 2019-05-08 French Compare
v2 2019-05-08 English Compare
v1 2019-05-08 English Compare

Showing 1 to 5 of 5